Cadila gets tentative approval for Esomeprazole capsules Cadila gets tentative approval for Esomeprazole capsules Nidhi Jani / Monday, January 21, 2019 0 551 Article rating: 5.0 Zydus Cadila today informed the bourses that it has received tentative USFDA approval to market Esomeprazole magnesium delayed-release capsules. These tablets are used to treat certain stomach and esophagus problems such as acid reflux, ulcers, etc. Read more
Results to watch out on Tuesday, January 22 Results to watch out on Tuesday, January 22 DSIJ Intelligence / Monday, January 21, 2019 0 1140 Article rating: 5.0 The following stocks would be in focus during Tuesday’s trading session in light of their results announcement on January 22: Asian Paints, Havells, TVS Motor Company, Oberoi Realty and Shree Cement. Read more
Q3FY19: Muthoot Capital net profit up by 48 per cent Q3FY19: Muthoot Capital net profit up by 48 per cent DSIJ Intelligence / Monday, January 21, 2019 0 959 Article rating: 5.0 The listed entity of Muthoot Pappachan Group, Muthoot Capital Services announced its Q3FY19 earnings. The NBFC gave a stellar performance for the quarter, however the shares of the company were volatile on Monday. Read more
Wockhardt gains on launch of leukemia drug Wockhardt gains on launch of leukemia drug DSIJ Intelligence / Monday, January 21, 2019 0 806 Article rating: 5.0 The pharmaceutical company has received approval from the USFDA for an ANDA for 100mg and 400mg tablets of Imatinib Mesylate. The shares of the company climbed approximately 3.4 per cent on Monday. Read more
PSP Projects surges 3 per cent on receiving order PSP Projects surges 3 per cent on receiving order Nidhi Jani / Monday, January 21, 2019 0 1157 Article rating: 5.0 PSP Projects' total work orders on a standalone basis stood at Rs. 1,376.79 crore, till date in FY19. While as on September 30, the company's order book stood at Rs. 2,576 crore, which are to be executed in the next 24 to 30 months. Read more